Year: 2025
Attached is a schedule of Landsbankinn‘s covered bond auctions in the domestic market in 2026.
Landsbankinn will explore other funding opportunities, including issuance of subordinated securities, in the domestic market with the aim of diversifying the funding base. The timing and amount of such issuance will depend on market conditions and general investor interest.
Landsbankinn reserves the right to make changes to the schedule for 2026 at its own discretion without prior notice.AttachmentIssue calendar 2026
Mondelēz Global LLC Expands Voluntary Recall of 2 SKUs of CHIPS AHOY! Baked Bites Brookie in the US
Written by Customer Service on . Posted in Public Companies.
EAST HANOVER, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) — Mondelēz Global LLC announced today an expansion of its December 24, 2025 voluntary recall in the United States of CHIPS AHOY! Baked Bites Brookie. This expansion includes one additional code date (10MAY2026) and two additional UPCs of product pouches inside the recalled carton units of CHIPS AHOY! Baked Bites Brookie.
This voluntary recall is being conducted because of an incorrect mixing process that resulted in the formation of small corn starch clumps in the product. Due to the characteristics and size of the small starch clumps, the clump could constitute a choking hazard, particularly in special risk groups, such as young children and the elderly.
This recall is limited exclusively to the CHIPS AHOY! Baked Bites Brookie products with Best When Used By Dates listed in the...
Resolutions of the Annual General Shareholders Meeting of VILNIAUS BALDAI AB on 30/12/2025
Written by Customer Service on . Posted in Public Companies.
On the 30 of December 2025 the Annual General Shareholders Meeting of VILNIAUS BALDAI AB adopted the following resolutions:
Agenda item #1: Consolidated Management Report. The Company‘s consolidated management report for the FY 2025 ended 31 August 2025 was presented.
Agenda item #2: Company‘s Auditor’s Report. The report of the audit company Grant Thornton Baltic UAB on the consolidated and the Company’s financial statements for the FY 2025, ended on 31 August 2025, was presented.
Agenda item #3: Approval of the Consolidated and Company’s financial statements for the year 2025 ended 31 August 2025. Resolution: to approve Consolidated and Company’s financial statements for the year 2025 ended 31 August, 2025.
Agenda item #4: Approval of the Company‘s profit distribution for the year 2025 ended 31 August 2025. Resolution:...
U.S. Global Investors Advances Smart Beta 2.0 Strategy as GOAU ETF Transitions to Active Management and WAR ETF Marks One-Year Milestone
Written by Customer Service on . Posted in Public Companies.
GOAU Climbed Higher in 2025Market Price Per Share, Year-to-Date Through December 18, 2025The WAR ETF Has Outperformed the Market Since InceptionNAV Percent Change | Dec. 20, 2024 – Nov. 28., 2025San Antonio, TX, Dec. 30, 2025 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, is proud to celebrate two significant milestones on December 30, 2025. In a year marked by historic moves in gold, the U.S. Global GO GOLD and Precious Metals Miner ETF (GOAU) will transition from passive indexing to active management, enabling greater agility while remaining grounded in the Company’s proprietary Smart Beta 2.0 investment discipline.
At the same time, the U.S. Global Technology...
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
Written by Customer Service on . Posted in Public Companies.
Tainan City, Taiwan, Dec. 30, 2025 (GLOBE NEWSWIRE) — Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced that on December 23, 2025, it entered into an agreement (the “Agreement”) with an unrelated third party, Wei Ha Hui (the “Buyer”), pursuant to which the Company agreed to sell 100% of the issued and outstanding shares of Advanced Biomed (HK) Limited, a Hong Kong company and a wholly owned subsidiary of the Company (the “Hong Kong Subsidiary”), for an aggregate purchase price of US$23,000 based on a valuation report commissioned by the Company, subject to the terms and conditions set forth in the Agreement.
All intellectual property owned by the...
ILLR Remains Confident in Nasdaq Appeal and Imminent Filing Compliance
Written by Customer Service on . Posted in Public Companies.
Los Angeles , Dec. 30, 2025 (GLOBE NEWSWIRE) — Triller Group Inc. (“Triller Group” or “the Company”) today announced that it received a determination letter from a Nasdaq Hearings Panel on December 26, 2025, confirming the suspension of trading on the Nasdaq Stock Market effective at the open of the market on December 30, 2025 and delisting of the Company’s securities. This decision stems from the Company not having been able to file two periodic reports by a deadline of December 24, 2025 set by the Hearings Panel.
The Company’s operations have been progressing in a normal manner, and no deficiencies or irregularities have been identified that materially affect the Company’s financial position or operational integrity. The filing delay is attributable primarily to one remaining technical matter involving the consolidation of accounts...
Totaligent Evaluates Relaunch of Previously Operated Crypto Mining Activities as Part of 2026 Strategy
Written by Customer Service on . Posted in Public Companies.
BOCA RATON, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — Totaligent, Inc. (OTCID: TGNT) (“the Company”), a provider of intelligent business marketing and data solutions, today announced that it is evaluating the potential relaunch of its crypto mining operations as part of the Company’s strategic initiatives for 2026.
This review follows the Company’s recent completion of QA testing across key components of the Totaligent platform, including Smart Capture, Display Ads, Analytics, Pulse, and campaign management tools, supporting the platform’s continued progression toward broader market deployment. As the platform advances, Totaligent is expanding its focus to include a review of its technology roadmap and operational requirements to support future product enhancements and scalability.
Evaluating AI Capabilities and Strategic Participation...
Robex Shareholders Approve PDI Merger
Written by Customer Service on . Posted in Mergers And Acquisitions.
QUEBEC CITY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce that at its special meeting of shareholders (the “Meeting”) held today, shareholders (“Robex Shareholders”) voted overwhelmingly in favour of the special resolution (the “Arrangement Resolution”) approving the previously announced merger with Predictive Discovery Limited (“Predictive”) pursuant to which Predictive, through its direct wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Robex (“Robex Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Québec).
Voting Results
The Arrangement Resolution was approved by 94.54% of votes cast by Robex Shareholders represented in person or by proxy at the Meeting, satisfying the required approval threshold...
Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market
Written by Customer Service on . Posted in Public Companies.
HONG KONG, Dec. 30, 2025 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited(“GV Hong Kong”), has official appointed Ms. Wenxuan Cai as Chief Executive Officer of GV Hong Kong, effective immediately.
In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. This milestone marks GV’s formal transition from strategic positioning to active on-the-ground revenue generation.
Strengthening Leadership to Drive Market Execution
Ms. Cai joins the Company with nearly two decades of extensive experience in market expansion, brand commercialization, and building...
Nukkleus Completes Tiltan Acquisition, Adds 30 Years of Defense AI Leadership to Portfolio
Written by Customer Service on . Posted in Mergers And Acquisitions.
Israeli defense technology pioneer, supplier to IAI, Elbit, and Rafael, now a wholly owned Nukkleus subsidiary
NEW YORK and TEL AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK), (the “Company”), a strategic acquirer and developer of high-growth aerospace and defense businesses, today announced the closing of its acquisition of Tiltan Software Engineering Ltd. (“Tiltan”), a 30-year leader in defense AI simulation, synthetic data generation, and GPS-denied navigation systems. Tiltan is now a wholly owned subsidiary of the Company.
Tiltan’s technology is embedded in some of the world’s most advanced defense programs. Tiltan’s simulation platforms train pilots and operators for Israel Aerospace Industries, its synthetic data accelerates machine learning development for Elbit Systems, and its GPS-denied...
